These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 12234220

  • 1. Testing for human papillomavirus in women with abnormal pap smear results.
    Sawaya GF, Smith-McCune K.
    JAMA; 2002 Sep 18; 288(11):1350-1; author reply 1351-2. PubMed ID: 12234220
    [No Abstract] [Full Text] [Related]

  • 2. Testing for human papillomavirus in women with abnormal pap smear results.
    McCaffery KJ, Waller J, Forrest S, Wardle J.
    JAMA; 2002 Sep 18; 288(11):1350; author reply 1351-2. PubMed ID: 12234219
    [No Abstract] [Full Text] [Related]

  • 3. Abnormal pap smears in adolescents.
    Bacon J, Francoeur D, Goldfarb AF, Breech LL.
    J Pediatr Adolesc Gynecol; 2003 Jun 18; 16(3):157-66. PubMed ID: 12804941
    [No Abstract] [Full Text] [Related]

  • 4. Is there a role for human papillomavirus testing in clinical practice?
    Kaufman RH.
    Obstet Gynecol; 2001 Nov 18; 98(5 Pt 1):724-5. PubMed ID: 11704159
    [No Abstract] [Full Text] [Related]

  • 5. Evaluating the role of HPV testing for women with equivocal Papanicolaou test findings.
    Cox JT.
    JAMA; 1999 May 05; 281(17):1645-7. PubMed ID: 10235161
    [No Abstract] [Full Text] [Related]

  • 6. Extended duration of the detectable stage by adding HPV test in cervical cancer screening.
    van den Akker-van Marie ME, van Ballegooijen M, Rozendaal L, Meijer CJ, Habbema JD.
    Br J Cancer; 2003 Nov 17; 89(10):1830-3. PubMed ID: 14612887
    [Abstract] [Full Text] [Related]

  • 7. HPV testing in cervical screening.
    Cuzick J.
    Pharmacoepidemiol Drug Saf; 2001 Nov 17; 10(1):33-6. PubMed ID: 11417064
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
    Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA.
    JAMA; 1999 May 05; 281(17):1605-10. PubMed ID: 10235153
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA.
    JAMA; 2002 Oct 09; 288(14):1749-57. PubMed ID: 12365959
    [Abstract] [Full Text] [Related]

  • 11. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.
    Fait G, Kupferminc MJ, Daniel Y, Geva E, Ron IG, Lessing JB, Bar-Am A.
    Gynecol Oncol; 2000 Nov 09; 79(2):177-80. PubMed ID: 11063640
    [Abstract] [Full Text] [Related]

  • 12. Cervical cancer: developments in screening and evaluation of the abnormal Pap smear.
    Walsh JM.
    West J Med; 1998 Nov 09; 169(5):304-10. PubMed ID: 9830367
    [Abstract] [Full Text] [Related]

  • 13. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
    Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C.
    Eur J Gynaecol Oncol; 2004 Nov 09; 25(5):577-84. PubMed ID: 15493169
    [Abstract] [Full Text] [Related]

  • 14. Role of HPV-assay as an adjuvant to Pap's smear for diagnosis of carcinoma cervix.
    Shahi SK, Ranga S, Srivastava R.
    Indian J Pathol Microbiol; 2000 Oct 09; 43(4):383-5. PubMed ID: 11344599
    [No Abstract] [Full Text] [Related]

  • 15. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
    Wright TC, Denny L, Kuhn L, Pollack A, Lorincz A.
    JAMA; 2000 Jan 05; 283(1):81-6. PubMed ID: 10632284
    [Abstract] [Full Text] [Related]

  • 16. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M.
    J Natl Cancer Inst; 2003 Jan 01; 95(1):46-52. PubMed ID: 12509400
    [Abstract] [Full Text] [Related]

  • 17. Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer.
    Costa S, Sideri M, Syrjänen K, Terzano P, De Nuzzo M, De Simone P, Cristiani P, Finarelli AC, Bovicelli A, Zamparelli A, Bovicelli L.
    Acta Cytol; 2000 Jan 01; 44(3):310-8. PubMed ID: 10833984
    [Abstract] [Full Text] [Related]

  • 18. HPV testing is not useful for LSIL Triage--but stay tuned.
    Stoler MH.
    Adv Anat Pathol; 2001 May 01; 8(3):160-4. PubMed ID: 11345239
    [No Abstract] [Full Text] [Related]

  • 19. Detection of human papillomavirus on Papanicolaou-stained cervical smears using indirect in situ polymerase chain reaction hybridization.
    Manavi M, Bauer M, Pischinger K, Czerwenka K.
    Arch Pathol Lab Med; 2001 Mar 01; 125(3):353-7. PubMed ID: 11231482
    [Abstract] [Full Text] [Related]

  • 20. Benefits and costs of using HPV testing to screen for cervical cancer.
    Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, Gold K, Barter J, Shah K.
    JAMA; 2002 May 08; 287(18):2372-81. PubMed ID: 11988058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.